Certara Operating Margin from 2010 to 2026

CERT Stock  USD 6.65  0.09  1.37%   
Certara's shows a recovering structural trend supported by multi-year data. Analyst models indicate potential upside toward 0.05.
Financial statement trends for Certara provide structured context on operating performance and capital structure. This context pairs drivers like Tax Provision of 9.7 M, Depreciation And Amortization of 54.9 M or Interest Expense of 18 M and ratios such as Price To Sales Ratio of 3.21, Dividend Yield of 0.0 or PTB Ratio of 1.26 with Certara Valuation and Volatility views.
  
Build AI portfolio with Certara Stock
Certara Correlation provides competitor comparison context for Certara. The view supports competitor context.
Our How to Buy Certara Stock guide explains the steps to invest in Certara stock.
The evolution of Operating Margin for Certara provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Certara compares to historical norms and industry peers.

Latest Certara's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Certara over the last few years. It is Certara's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Certara's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.02 %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

Certara Operating Margin Regression Statistics

Arithmetic Mean-0.01
Geometric Mean 0.04
Coefficient Of Variation-744.33
Mean Deviation 0.05
Median-0.03
Standard Deviation 0.06
Sample Variance 0.0035
Range0.212
R-Value 0.34
Mean Square Error 0.0033
R-Squared 0.12
Significance 0.18
Slope 0.004
Total Sum of Squares 0.06

Certara Operating Margin History

2026 0.0527
2025 0.0502
2024 -0.004494
2023 -0.12
2022 0.0969
2021 0.0475
2020 -0.1

Stock Overview, Methodology & Data Sources

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. Certara operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1054 people. As a mid-cap equity, Certara is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 0.98, profit margin of -0.38%. Certara has a market cap of 1.04 B, ROE of -0.15%.

Methodology

Unless otherwise specified, financial data for Certara is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Certara (USA Stocks:CERT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Certara is covered by 14 analysts. 7 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Evercore ISI, Morgan Stanley, BMO Capital Markets, Oppenheimer & Co., Guggenheim Securities, HSBC Global Research, Raymond James, Bernstein Research, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Certara Stock Analysis

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bonds Directory
Find actively traded corporate debentures issued by US companies
Money Managers
Screen money managers from public funds and ETFs managed around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals